Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Barbara Oliviero

Has grant

Researcher

Fondazione IRCCS Policlinico San Matteo

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Recent Grants

Grant: Close

Effect of proteasome and VEGF receptor inhibitors on NKG2D ligand expression on hepatocellular carcinoma cells: implications for immunotherapy of liver cancer

Open Date: 2014-01-01

Close Date: 2018-01-01

Grant: Close

B cell responses in COVID-19: generation of SARS-CoV-2 neutralizing human monoclonal antibodies to efficiently contrast wild-type and emerging variants

Open Date:

Close Date:

Articles (11)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (2)

Jesus M. Banales

SPAIN

View details

ANNA CARETTI

Università degli Studi di Torino

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Barbara Oliviero

Research Interests

Explore related searches

Recent Grants

Articles (11)

Development, Expansion, and Histological Characterization of Patient-Derived Liver Organoids for Drug Screening and Disease Modeling.

Lipid Metabolism Reprogramming in Tumor-Associated Macrophages Modulates Their Function in Primary Liver Cancers

Neoadjuvant immunotherapy in resectable hepatocellular carcinoma: A meta-analysis of the current evidence.

Cholangiocarcinoma cells direct fatty acids to support membrane synthesis and modulate macrophage phenotype.

From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation.

Navigating the evidence for hepatocellular carcinoma treatment: Surgery <i>vs</i> radiofrequency ablation through sentiment and meta-analysis.

VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference

Long‐term dynamics of natural killer cells in response to SARS‐CoV‐2 vaccination: Persistently enhanced activity postvaccination

Ceramide present in cholangiocarcinoma-derived extracellular vesicle induces a pro-inflammatory state in monocytes.

Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host’s Immunity

TLRs: Innate Immune Sentries against SARS-CoV-2 Infection

Collaborators (2)

Jesus M. Banales

ANNA CARETTI

Make your next move.

Barbara Oliviero

Research Interests

Explore related searches

Recent Grants

Articles (11)

Development, Expansion, and Histological Characterization of Patient-Derived Liver Organoids for Drug Screening and Disease Modeling.

Lipid Metabolism Reprogramming in Tumor-Associated Macrophages Modulates Their Function in Primary Liver Cancers

Neoadjuvant immunotherapy in resectable hepatocellular carcinoma: A meta-analysis of the current evidence.

Cholangiocarcinoma cells direct fatty acids to support membrane synthesis and modulate macrophage phenotype.

From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation.

Navigating the evidence for hepatocellular carcinoma treatment: Surgery &lt;i&gt;vs&lt;/i&gt; radiofrequency ablation through sentiment and meta-analysis.

VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference

Long‐term dynamics of natural killer cells in response to SARS‐CoV‐2 vaccination: Persistently enhanced activity postvaccination

Ceramide present in cholangiocarcinoma-derived extracellular vesicle induces a pro-inflammatory state in monocytes.

Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host’s Immunity

TLRs: Innate Immune Sentries against SARS-CoV-2 Infection

Collaborators (2)

Jesus M. Banales

ANNA CARETTI

Make your next move.

Navigating the evidence for hepatocellular carcinoma treatment: Surgery <i>vs</i> radiofrequency ablation through sentiment and meta-analysis.